Phelthico Pharma posts PAT of Rs 43.77 cr for Q3

Mumbai, Oct 31 (UNI) Neutraceutical player Plethico Pharmaceuticals has posted profit after tax (PAT) at Rs 43.77 crore, up by four per cent, for its third quarter ended September 30.

During the period, the company's revenues touched Rs 154.05 crore, up by 25 per cent, with herbal and nutraceutical products accounting for 84 per cent of the revenue, said a company release here today.

The US market accounted for 39 per cent of the company's revenues followed by Third Front markets such as LAC (Latin America&Caribbean), SEA (South East Asia), GCC 27 pc, CIS 14 pc, Africa 13 pc and India seven pc, it added.

UNI ZC SSS VKG1825